SEMENTIS
Sementis is an Australian unlisted public biotechnology company that is using its proprietary SCV platform. The Company is using its proprietary Sementis Copenhagen Vector (SCV) platform technology to generate a portfolio of innovative vaccine candidates for the prevention of allergies and infectious diseases. SCV is a novel vector platform that uses a replication-incompetent vaccinia virus to stimulate both B-cell and T-cell immune responses. The genes for disease antigens are added to the SCV, which upon inoculation elicits a potent immune response to the disease state.
SEMENTIS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.sementis.com.au
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Mobile Non Scaleable Content
Current Employees Featured
Official Site Inspections
http://www.sementis.com.au Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
- Host name: 104.21.96.1
- IP address: 104.21.96.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sementis"
Company - Sementis
Sementis is an Australian unlisted public biotechnology company based in Adelaide, South Australia that is dedicated to the research and development of new vaccines to tackle the world’s most challenging diseases. Sementis R&D …See details»
About - Sementis
Sementis was founded in 2009, based on the invention of the SCV platform system. This technology combines a viral vector genetically engineered for safety with a commercial …See details»
Sementis Ltd: Contact Details and Business Profile
Sementis Ltd is an Australian unlisted public biotechnology company based in Adelaide, South Australia and dedicated to research and development of new vaccines to tackle viruses and …See details»
Sementis Ltd Overview | SignalHire Company Profile
Sementis Ltd is an Australian unlisted public biotechnology company based in Adelaide, ... Organization Website: sementis.com.au : Sementis Ltd industries Biotech: Headquarters …See details»
Sementis - Overview, News & Similar companies | ZoomInfo.com
Nov 5, 2018 Sementis is an Australian unlisted public biotechnology company that is using its proprietary Sementis Copenhagen Vector (SCV) platform technology to generate a portfolio of …See details»
Sementis - Crunchbase Company Profile & Funding
Sementis is an Australian unlisted public biotechnology company that is using its proprietary SCV platform. The Company is using its proprietary Sementis Copenhagen Vector (SCV) platform …See details»
Sementis Company Profile - Office Locations, Competitors ... - Craft
Sementis is a biotechnology company using its proprietary SCV platform technology to generate vaccine candidates for the prevention of infectious diseases and the treatment of immune …See details»
Sementis Ltd. - CMOCRO
Sementis is an Australian unlisted public biotechnology company that is dedicated to the research and development of new vaccines to tackle the world’s most challenging diseases. Sementis\' …See details»
Sementis Ltd - AusBiotech
Sementis Ltd is developing a novel vaccine platform designed to deliver new vaccines and immunotherapies to the world’s most challenging and complex diseases by unlocking the …See details»
Vaccine developer Sementis appoints chief operating officer
Feb 15, 2022 "Sementis has developed Australia’s most advanced viral vector vaccine platform technology that can be adapted to fight a wide range of diseases into the future," said the …See details»
Sementis - Startup Galaxy
Sementis Ltd is an Australian unlisted public biotechnology company based in Adelaide, South Australia and dedicated to research and development of new vaccines to tackle viruses and …See details»
New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the appointment of a new CEO. Following a global search, Dr Anne …See details»
New leadership for vaccine platform technology company Sementis
Sep 14, 2023 Sementis owns an advanced vaccine platform technology and a portfolio of candidates in development. It has government grant funding and key institutional partnerships …See details»
Well-deserved recognition for vaccine collaboration leader
Feb 27, 2024 +61 (3) 8840 5200 [email protected]. Follow us on LinkedIn and Twitter. IMS Login Login In-kind Portal Login Certex. DMTC. Menu. News. Well-deserved recognition …See details»
Fabricant d'objets du quotidien | Sementis
Sementis contribue à réindustrialiser, de manière responsable et locale, des savoir-faire perdus sur le territoire français. Nous accompagnons les marques à développer leur gamme d’objets …See details»
Technology - Sementis
Sementis is at the leading edge of vaccine development, with the Sementis Copenhagen Vector system currently Australia’s most advanced non-replicating viral vector vaccine platform …See details»
Adelaide's Healthtech Sector Hits Milestone with Global Market ...
The participating companies, representing a diverse range of healthtech solutions, included Corcillum Systems, AddendAI, Fusetec, EyeSpace, ResearchSat, Osteo-X, Personify Care, …See details»
News - Sementis
February 2024 Sementis was delighted to be recognised at the 2024 DMTC Annual Conference, and our CEO Dr Anne Collins... News. New Sementis CEO to Advance Vaccine Technology. …See details»
Sementis’ quest for an Australian second-generation COVID-19 …
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a second-generation COVID-19 vaccine using their proprietary viral …See details»